این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
جمعه 27 شهریور 1405
Research in Molecular Medicine
، جلد ۹، شماره ۴، صفحات ۰-۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
In silico design a multivalent epitope vaccine against SARS-CoV-2 for Iranian populations
چکیده انگلیسی مقاله
Background: Due to high genetic variation in human leukocyte antigen )HLA( alleles, epitope-based vaccines don't show equal efficacy in different human populations. therefore, we proposed a multi-epitope vaccine against SARS-CoV-2 for Iranian populations. Materials and Methods: For this purpose, the proteins without allergenicity and high antigenicity as well as conservancy level from SARS-CoV-2 were subjected to in silico B- and T-cell epitope mapping. T-cell epitope mapping process was performed based on the most frequent human leukocyte antigen (HLA) alleles in Iran. The B- and T-cell epitopes were screened based on their allergenicity, antigenicity and hemolytic potential and the epitopes with appropriate properties were subjected for final vaccine construct. The screened B- and T-cell epitopes were organized in the final vaccine construct. The secondary and tertiary structures of the proposed vaccine were predicted and its affinity to HLA-I, HLA-II, toll like receptor (TLR-3) and TLR-4 by molecular docking method. Additionally, probable immune responses against the vaccine were predicted trough immune simulation. Results: The final vaccine construct was includes six, eight and six linear B-cell epitopes, HLA-I restricted epitopes and HLA-II restricted epitopes respectively. The results of evaluations confirmed that the proposed vaccine is a 60.3 kDa stable, water soluble and high antigenic protein with high affinity to the selected target molecules and could elicits both humoral and cellular responses. Conclusion: Altogether, the study suggests that the proposed vaccine can be considered as an effective anti-COVID-19 vaccine candidate for Iranian population.
کلیدواژههای انگلیسی مقاله
SARS-CoV-2, Epitope, Vaccine, In silico
نویسندگان مقاله
| Faezeh Soltanveis
1Department of Biology, Payame Noor University, Tehran, Iran
| Mokhtar Nosrati
Independent researcher
نشانی اینترنتی
http://rmm.mazums.ac.ir/browse.php?a_code=A-10-819-2&slc_lang=en&sid=1
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
بیوانفورماتیک
نوع مقاله منتشر شده
پژوهشی
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات